Murine 3F8 monoclonal antibody

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMurine 3F8 monoclonal antibody
Drug Alias Name小鼠3F8单克隆抗体3F8小鼠单克隆抗体3F8-MAbMAb-3F8MOAB-3F8
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionImmunostimulantsDisialoganglioside GD2 inhibitors
TargetsDisialoganglioside GD2
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsNeuroblastoma

Other Information

ATC CodeN/A
Related LinksN/A